45602 Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; NIH Pathways to 

Independence Award (K99/R00) Review. 

Date: November 15, 2017. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Gateway Plaza, 7201 Wisconsin Avenue, 

Suite 533, Bethesda, MD 20814 

(Telepresence). 

Contact Person: Richard C. Palmer, DRPH, 

Health Scientist Administrator, National 

Institute on Minority Health and Health 

Disparities, National Institutes of Health, 

6707 Democracy Blvd., Suite 800, Bethesda, 

MD 20906, (301) 451–2432, richard.palmer@

nih.gov. 

Dated: September 25, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20860 Filed 9–28–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request Revision to 

Identifying Experts in Prevention 

Science Methods To Include on NIH 

Review Panels, Office of Disease 

Prevention (NIH ODP) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. This proposed 

information collection was previously 

published in the Federal Register on 

July 6, 2017, page 31337 (82 FR 31337) 

and allowed 60 days for public 

comment. No public comments were 

received. The purpose of this notice is 

to allow an additional 30 days for public 

comment. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice, especially 

regarding the estimated public burden 

and associated response time, should be 

directed to the: Office of Management 

and Budget, Office of Regulatory Affairs, 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974, Attn: Desk Officer 

for NIH. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact: Dr. Ranell Myles, 

Public Health Analyst, NIH Office of 

Disease Prevention, 6100 Executive 

Blvd., Room 2B03, Bethesda, MD 20892 

or call (301) 827–5579 or email your 

request, including your address to 

prevention@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The Office 

of Disease Prevention, National 

Institutes of Health, may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: Identifying 

Experts in Prevention Science Methods 

to Include on NIH Review Panels,— 

REVISION, Office of Disease Prevention 

(ODP), National Institutes of Health 

(NIH) (OMB# 0925–0728, Expiration 

date 12/31/2018) 

Need and Use of Information 

Collection: The Office of Disease 

Prevention (ODP) is the lead Office at 

the National Institutes of Health (NIH) 

responsible for assessing, facilitating, 

and stimulating research in disease 

prevention and health promotion, and 

disseminating the results of this 

research to improve public health. 

Prevention is preferable to treatment, 

and research on disease prevention is an 

important part of the NIH’s mission. The 

knowledge gained from this research 

leads to stronger clinical practice, health 

policy, and community health 

programs. ODP collaborates with the 

NIH, other Department of Health and 

Human Services (DHHS) agencies, and 

other public and private partners to 

achieve the Office’s mission and goals. 

One of our priorities is to promote the 

use of the best available methods in 

prevention research and support the 

development of better methods. One of 

our strategies is to help the Center for 

Scientific Review (CSR) identify experts 

in prevention science methods to 

include on their review panels. This 

will strengthen the panels and improve 

the quality of the prevention research 

supported by the NIH. To identify 

experts in prevention science methods, 

we worked with our contractor, IQ 

Solutions, Inc., to develop online 

software which will allow us to collect 

scientists’ names, contact information, 

and resumes, as well as to have those 

scientists identify their level of 

expertise in a variety of prevention 

science methods and content areas. The 

information collected with this software 

was used to create a web-based tool that 

CSR staff can use to identify scientists 

with expertise in specific prevention 

science methods and content areas for 

invitation to serve on one of the CSR 

review panels. This system will also be 

shared with review staff in the other 

Institutes and Centers at the NIH, as 

well as other DHHS agencies, to use in 

the same way. Given our plans to create 

an automated system for reviewer 

information collection, we are now 

seeking OMB approval for an extension 

and the addition of more questions. 

This PRA clearance request is for the 

collection of additional data not 

collected in the previously deployed 

online software and survey including 

additional study design topics, research 

methods topics, content topics, as well 

as the geographic region of research, and 

the income category of the region/ 

country in which the research is 

performed. The request also includes 

asking researchers who have already 

completed previous versions of the 

survey to update their information 

based on the revised additional topics. 

OMB revision approval is requested 

for 3 years. There are no costs to 

respondents other than their time. The 

total estimated annualized burden hours 

are 1,550. 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices 45603 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Investigators ................................................................................................... 3,120 1 25/60 1,300 

Returning Investigators to update information .............................................. 1,000 1 15/60 250 

Total ........................................................................................................ 4,120 4,120 ........................ 1,550 

Dated: September 24, 2017. 

Lawrence A. Tabak, 

Principal Deputy Director, National Institutes 

of Health. 

[FR Doc. 2017–20885 Filed 9–28–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Minority Health 

and Health Disparities; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; ZMD1 DRI (J1) NIH 

Support for Conferences and Scientific 

Meetings (Parent R13). 

Date: October 23, 2017. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Gateway Plaza, 533, 7201 Wisconsin Avenue, 

Suite 533, Bethesda, MD 20814 

(Telepresence). 

Contact Person: Deborah Ismond, Ph.D., 

Scientific Review Officer, Division of 

Scientific Programs, National Institute on 

Minority Health and Health Disparities, 

National Institutes of Health, 7201 Wisconsin 

Ave., Suite 525, Bethesda, MD 20814, (301) 

594–2704, ismonddr@mail.nih.gov. 

Dated: September 25, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20859 Filed 9–28–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Inherited 

Disease Research Access Committee. 

Date: November 9, 2017. 

Time: 11:30 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 3049, 

5635 Fishers Lane, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Barbara J. Thomas, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, National Institutes of Health, 5635 

Fishers Lane, Ste. 4076, MSC 9306, Bethesda, 

MD 20892–9306, 301–402–0838, 

barbara.thomas@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: September 26, 2017. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20988 Filed 9–28–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Planning NIDDK 

Clinical Trials. 

Date: November 9, 2017. 

Time: 9:00 a.m. to 10:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Elena Sanovich, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 7351, 6707 Democracy Boulevard, 

Bethesda, MD 20892–2542, 301–594–8886, 

sanoviche@mail.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK Program 

Project (P01). 

Date: November 14, 2017. 

Time: 1:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Jason D. Hoffert, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 7343, 6707 Democracy Boulevard, 


asabaliauskas on DSKBBXCHB2PROD with NOTICES